Market Tracker

02/24 5:16pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

10.36
Delayed Data
As of Feb 24
 +0.12 / +1.17%
Today’s Change
3.80
Today|||52-Week Range
10.84
+19.91%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close10.24
Today’s open10.22
Day’s range10.06 - 10.43
Volume1,141,807
Average volume (3 months)1,327,660
Market cap$725.7M
Dividend yield--
Data as of 3:59pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-1,033.33%
Earnings growth (this year)+112.95%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-80.45%
P/E ratio64.8
Price/Sales49.26
Price/Book8.01

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...+0.15+1.09%
CLLSCellectis SA-0.74-3.56%
AMPHAmphastar Pharmaceut...+0.38+2.57%
ADROAduro Biotech Inc+0.20+1.79%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$8.7M
Annual profit (last year)-$39.1M
Net profit margin-450.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
Vice President-
Operations
Meryl J. Longval
Corporate headquarters
Tarrytown, New York

Forecasts